FDG PET-CT imaging in assessing interim response to neoadjuvant cisplatin-based chemotherapy (NAC) in muscle invasive bladder cancer (MIBC): A prospective study.

被引：0
|
作者：
Sridhar, Srikala S.
Power, Nicholas
Breau, Rodney H.
Cheng, Susanna Y.
Pond, Gregory Russell
Chung, Peter W. M.
Metser, Ur
Levine, Mark Norman
Mukherjee, Som D.
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] London Hlth Sci Ctr, London, ON, Canada
[3] Ottawa Hosp, Ottawa, ON, Canada
[4] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[5] McMaster Univ, Ontario Clin Oncol Grp, Hamilton, ON, Canada
[6] Univ Hlth Network, Radiat Med Program, Princess Margaret Canc Ctr, Toronto, ON, Canada
[7] Princess Margaret Hosp, Toronto, ON, Canada
[8] Ontario Clin Oncol Grp, Hamilton, ON, Canada
[9] McMaster Univ, Dept Oncol, Juravinski Canc Ctr, Hamilton, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
460
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant cisplatin-based chemotherapy in "primary" and "secondary" muscle-invasive bladder cancer-is it a surrogate for molecular subtypes?
    Szarvas, Tibor
    Olah, Csilla
    Reis, Henning
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 : S176 - S179
  • [42] Perioperative cisplatin-based chemotherapy for muscle-invasive bladder cancer: a decision analysis
    Luca Afferi
    Beate Jahn
    Amar H. Kelkar
    Stijntje W. Dijk
    Zach M. Feldman
    Zachary J. Ward
    Marco Moschini
    Richard Cathomas
    Joaquim Bellmunt
    Andrea Gallioli
    Alberto Breda
    Christian D. Fankhauser
    Agostino Mattei
    Steven L. Chang
    Uwe Siebert
    World Journal of Urology, 43 (1)
  • [43] Association of an immune gene signature with pathologic response and outcome after neoadjuvant pembrolizumab (pembro), compared to neoadjuvant chemotherapy (NAC), in muscle-invasive bladder cancer (MIBC)
    Necchi, Andrea
    Raggi, Daniele
    Briganti, Alberto
    Fare, Elena
    Giannatempo, Patrizia
    Marandino, Laura
    Bianchi, Marco
    Gallina, Andrea
    Salonia, Andrea
    Gandaglia, Giorgio
    Fossati, Nicola
    Capitanio, Umberto
    Montorsi, Francesco
    Boormans, Joost L.
    Liu, Yang
    de Jong, Joep
    Black, Peter C.
    Dittamore, Ryan
    Davicioni, Elai
    Gibb, Ewan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [44] Impact of angiotensin-converting enzyme inhibitors (ACEi) on pathologic complete response with neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (MIBC).
    Thomas, Jonathan
    Skelton, William Paul
    Fallah, Parvaneh
    Jain, Rohit K.
    Ravi, Praful
    Mantia, Charlene
    McGregor, Bradley Alexander
    Nuzzo, Pier Vitale
    Adib, Elio
    El Zarif, Talal
    Curran, Catherine
    Preston, Mark A.
    Clinton, Timothy Nguyen
    Li, Roger
    Steele, Graeme S.
    Kassouf, Wassim
    Freeman, Dory
    Pond, Gregory Russell
    Jain, Rakesh K.
    Sonpavde, Guru P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [45] Impact of intra-tumoral immunity on predicting response and survival after neoadjuvant cisplatin-based chemotherapy in patients with muscle invasive bladder cancer
    Mendoza-Valderrey, Alberto
    Choe, Jane
    Kessler, Daria M.
    Jimenez, Gianna
    Li, Xinmin
    Kolker, Steven
    Allen, Warren
    Linehan, Jennifer A.
    Twardowski, Przemyslaw W.
    Ascierto, Maria Libera
    CANCER MEDICINE, 2024, 13 (15):
  • [46] PDL1 STATUS IN MUSCLE INVASIVE UROTHELIAL BLADDER CARCINOMA (MIBC) IN THE CONTEXT OF NEOADJUVANT CISPLATIN BASED CHEMOTHERAPY
    Baras, Alexander
    Mendoza, Maria Angelica
    Guner, Gunes
    Gandhi, Nilay
    Liu, Jen-Jane
    Taube, Janis
    Bivalacqua, Trinity
    Netto, George
    JOURNAL OF UROLOGY, 2015, 193 (04): : E703 - E703
  • [47] PDL1 Status in Muscle Invasive Urothelial Bladder Carcinoma (MIBC) in the Context of Neoadjuvant Cisplatin Based Chemotherapy
    Angelica, Maria
    Rodriguez, Mendoza
    Baras, Alexander
    Guner, Clines
    Gandhi, Nilay
    Munari, Enrico
    Faraj, Sheila
    Taube, Janis
    Bivalacqua, Trinity
    Netto, George
    LABORATORY INVESTIGATION, 2015, 95 : 244A - 244A
  • [48] PDL1 Status in Muscle Invasive Urothelial Bladder Carcinoma (MIBC) in the Context of Neoadjuvant Cisplatin Based Chemotherapy
    Rodriguez, Maria Angelica Mendoza
    Baras, Alexander
    Guner, Gunes
    Gandhi, Nilay
    Munari, Enrico
    Faraj, Sheila
    Taube, Janis
    Bivalacqua, Trinity
    Netto, George
    MODERN PATHOLOGY, 2015, 28 : 244A - 244A
  • [49] Trends in neoadjuvant chemotherapy (NAC) use for muscle-invasive bladder cancer (MIBC): An updated report using the National Cancer Database (NCDB)
    Bergerot, Paulo Gustavo
    Sonpavde, Guru
    Nelson, Rebecca A.
    Agarwal, Neeraj
    Costa, Caroline Nadai
    Hsu, JoAnn
    Choueiri, Toni K.
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [50] Identification of molecular biomarkers of cisplatin-based chemosensitivity in patients undergoing neoadjuvant chemotherapy for muscle-invasive bladder cancer.
    Shah, Paras Hemant
    Lee, Annette
    Zhu, Xinhua
    Bradley, Thomas Paul
    Vira, Manish Arvind
    Korsunsky, Ilya
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345